Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Inoperable Neuro

Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 27 Jan 2026. The item focuses on Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas (SPRINKLE; phase I/II). Review the original article for the full source wording and details.